- Roper’s application software net revenue from continuing operations reached $984.4 million, surpassing the estimate of $941.7 million.
- Network software net revenue from continuing operations was slightly below expectations at $367.1 million, compared to the estimate of $374.6 million.
- Technology-enabled products net revenue from continuing operations was $413.1 million, under the estimate of $417.9 million.
- Adjusted EPS from continuing operations was $4.62, higher than the estimate of $4.53.
- Total net revenue from continuing operations was $1.77 billion, exceeding the estimate of $1.73 billion.
- Organic revenue from continuing operations grew by 4%, though slightly below the estimated 4.73% growth.
- The gross margin stood at 69.2%, just under the estimated 70%.
- Roper forecasts its adjusted EPS from continuing operations for the year to be between $18.21 and $18.25, aligning closely with the $18.24 estimate.
- For Q4 2024, the company anticipates adjusted EPS to be in the range of $4.70 to $4.74.
- Roper raised its full-year total revenue growth outlook to over 13% and maintains an expected organic revenue growth of approximately 6%.
- The company attributes the positive outlook to its strong Q3 results, expanding recurring revenue base, and increased demand for mission-critical solutions.
- Analyst ratings on Roper include 9 buys, 6 holds, and 2 sells.
“`
Roper Technologies on Smartkarma
Analysts at Baptista Research on Smartkarma are closely following the developments at Roper Technologies, a diversified technology firm. In their report titled “Roper Technologies Inc.: Enhanced Product Integration and SaaS Solutions Catalyzing Growth! – Major Drivers,” the research focuses on the company’s recent financial performance for the second quarter of 2024. Highlighting solid quarterly achievements and updated fiscal guidance, Roper Technologies aims to streamline operational processes and expand its market presence through strategic acquisitions. Baptista Research utilizes a Discounted Cash Flow (DCF) methodology to independently assess the factors that could impact the company’s stock price in the near future.
Furthermore, in another report by Baptista Research titled “Roper Technologies Inc.: Transition to Cloud and SaaS-based Offerings! – Major Drivers,” analysts emphasize the company’s strong start to the year with significant growth in revenue, EBITDA, adjusted DEPS, and free cash flow in Q1. The acquisition of Procare Solutions, a provider of software for the early childhood education market, marked a milestone for Roper Technologies. With total revenue and organic revenue up by 14% and 8% respectively, and EBITDA showing a 16% growth, the company demonstrates resilience and strategic expansion efforts, capturing the interest of independent analysts on Smartkarma.
A look at Roper Technologies Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
With a solid overall outlook based on Smartkarma Smart Scores, Roper Technologies appears well-positioned for long-term growth. Boasting a strong Growth score of 4, the company is poised to expand its presence and increase market share. Additionally, its Resilience score of 3 suggests that Roper Technologies is equipped to weather economic uncertainties and maintain stability in the face of challenges.
Roper Technologies‘ diverse product portfolio, which includes industrial controls, medical devices, and analytical instrumentation products, underscores its ability to adapt to changing market demands. While the company’s Value and Momentum scores are moderate at 3, indicating room for improvement, its strong Growth and Resilience scores bode well for its future performance in the industrial equipment sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
